GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Other Gross PPE

AngioLab (XKRX:251280) Other Gross PPE : ₩396.1 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab Other Gross PPE?

AngioLab's Other Gross PPE for the quarter that ended in Dec. 2023 was ₩396.1 Mil.

AngioLab's quarterly Other Gross PPE increased from Dec. 2021 (₩209.7 Mil) to Dec. 2022 (₩311.5 Mil) and increased from Dec. 2022 (₩311.5 Mil) to Dec. 2023 (₩396.1 Mil).

AngioLab's annual Other Gross PPE increased from Dec. 2021 (₩209.7 Mil) to Dec. 2022 (₩311.5 Mil) and increased from Dec. 2022 (₩311.5 Mil) to Dec. 2023 (₩396.1 Mil).

AngioLab Other Gross PPE Historical Data

The historical data trend for AngioLab's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab Other Gross PPE Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial 105.87 209.66 209.66 311.46 396.13

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE Get a 7-Day Free Trial 105.87 209.66 209.66 311.46 396.13

AngioLab Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

AngioLab (XKRX:251280) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » Other Gross PPE
Comparable Companies
XKRX:072520 XKRX:446440 XKRX:215380 XKRX:322970 XKRX:283100 XKRX:950220 XKRX:343090 XKRX:179530 XKRX:388610 XKRX:208340 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
Website
http://www.angiolab.co.kr
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab (XKRX:251280) Headlines

No Headlines